Literature DB >> 633012

Sickle cell syndromes. II. The sickle cell anemia-alpha-thalassemia syndrome.

G R Honig, M Koshy, R G Mason, L N Vida.   

Abstract

Five American black patients, ages 1 to 16 years, with the sickle cell anemia-alpha-thalassemia syndrome are described. Each patient had persistent microcytosis not explained by iron deficiency, and in each family the presence of alpha-thalassemia in combination with sickle cell trait was demonstrated in one of the parents. In one patient, in whom the diagnosis of sickle cell anemia was established at birth, an elevated level of Barts (gamma4) hemoglobin was also found. In these patients levels of alkali-resistant hemoglobin and reticulocyte counts were similar to those of sickle cell anemia patients of comparable age; however, stained smears of their peripheral blood rarely showed the presence of irreversibly sickled cells. No major ameliorative effect of the alpha-thalassemia on the clinical expression of the sickle cell disease of these patients was evident.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 633012     DOI: 10.1016/s0022-3476(78)80287-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Heterogeneity of sickle-cell anemia based on a profile of hematological variables.

Authors:  D J Odenheimer; C F Whitten; D L Rucknagel; S A Sarnaik; C F Sing
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

2.  Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Authors:  Irene Lubega; Christopher M Ndugwa; Edison A Mworozi; James K Tumwine
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

3.  Sickle cell disease in Saudi Arabs in early childhood.

Authors:  R P Perrine; P John; M Pembrey; S Perrine
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

4.  Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.

Authors:  D R Powars; W A Schroeder; J N Weiss; L S Chan; S P Azen
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

5.  Modification of hemoglobin H disease by sickle trait.

Authors:  K K Matthay; W C Mentzer; A M Dozy; Y W Kan; D F Bainton
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.